Log in
Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
Phase 4
Completed
Conditions
Acne
Interventions
Other: Parenteral involvement / intervention reminders
Other: Electronic reminders (voice, e-mail, text messages)
Other: More frequent than normal office visits
Other: No intervention or reminders
Subscribe
First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
61
Registration Number
NCT00437151
Locations
🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy